… imbalance and falls Lessening stress and anxiety Treating dyskinesia Identifying different types of Parkinson’s and … with two common antidepressants in the SAD-PD study . Dyskinesia research is a priority for MJFF. We’ve funded studies looking for novel drugs to treat dyskinesia and backed trials looking for improved delivery …

… focusing on targets that have the potential to alleviate dyskinesias, the excessive, uncontrollable movements … receptor gamma, as a potential target for treating dyskinesias. The possibility of providing evidence of the … mTORC1 as a Target for the Treatment of L-DOPA-induced Dyskinesia Gilberto Fisone, PhD, Karolinska Institutet, …

… two broad categories: targets for therapies to alleviate dyskinesias, the excessive, uncontrollable movements brought … (mGluR5) could prevent the development of levodopa-induced dyskinesias. The current award will allow her to take this … the MPTP-lesioned NHP Model for Treating Levodopa-induced Dyskinesia” Erwan Bezard, PhD, INSERM, France “Validation of …

… parkinsonism and in an epidemiological and genetic study on dyskinesias in patients with neuroleptic-induced movement … subinvestigator in a drug trial (sarizotan for treatment of dyskinesias in Parkinson patients) and carried out all …

… Cons and Complications Possible side effects may include dyskinesia (involuntary movement), difficulty sleeping, … that aren’t there). Some possible complications, such as dyskinesia, may relate to the levodopa boost rather than a …

… therapeutics for disease modification and reduction of dyskinesia. Dr. Koprich has conducted a number of studies …